Mibelas 24 Fe — Class I drug recall D-1093-2017
Terminated recall by Lupin Limited (Unit 1), reported 2017-08-23, distributed nationwide. Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills a
| Recall number | D-1093-2017 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Limited (Unit 1), Pithampur, N/A, India |
| Recall initiated | 2017-05-16 |
| Classified | 2017-08-15 |
| Reported by FDA | 2017-08-23 |
| Terminated | 2019-05-30 |
| Distributed | Nationwide (US) |
| Quantity | 24,652 tablets |
| NDC | 68180-0911-11, 68180-0911-13 |
| Lot numbers | 05/18, L600518 |
Product
Mibelas 24 Fe (Norethindrone acetate and Ethinyl estradiol 1 mg/0.02 mg chewable and ferrous Fumarate 75 mg) Tablets, wallet of 28 tablets (NDC 68180-911-11), Carton of 3 wallets (NDC 68180-911-13), Rx Only, Manufactured by: Lupin Limited, India, Distributed by Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202
Reason for recall
Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1093-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.